Cronos (CRON) Common Equity (2016 - 2026)
Cronos' (CRON) quarterly Common Equity came in at $1.1 billion in Q1 2026, down 3.69% year-on-year from $1.1 billion in Q1 2025, and down 6.06% quarter-over-quarter from $1.1 billion in Q4 2025.
Cronos (CRON) Common Equity (2016 - 2026) Analysis & Trends
Cronos' Common Equity history runs 11 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- On a quarterly basis, Common Equity fell 3.69% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 3.69% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 2.88% from the prior year.
- Common Equity declined to $1.1 billion in Q1 2026 per CRON's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Common Equity topped out at $1.3 billion in Q1 2022 and bottomed at $1.1 billion in Q2 2024.
- The 5-year median for Common Equity is $1.1 billion (2025), against an average of $1.1 billion.
- Across the five-year window, Common Equity retreated 18.21% in 2022 and climbed 7.05% in 2025, its largest moves.
- Year by year, Common Equity stood at $1.1 billion in 2022, then retreated by 3.93% to $1.1 billion in 2023, then climbed by 1.36% to $1.1 billion in 2024, then increased by 2.88% to $1.1 billion in 2025, then dropped by 6.06% to $1.1 billion in 2026.
- Per Business Quant, the three latest CRON Common Equity figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 1.13 Bn |
| Mar 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 1.11 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.06 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.10 Bn |
| Sep 30, 2023 | 1.12 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.14 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 1.33 Bn |
| Sep 30, 2021 | 1.46 Bn |
| Jun 30, 2021 | 1.39 Bn |